Brief: Lidds Liproca Depot Phase IIb Study Results Presented At EMUC19 Showing Both Primary And Secondary Endpoints Being Met
16/11/2019 09:19
Nov 16 (Reuters) - Lidds AB LIDDS.ST :
* LIDDS LIPROCA® DEPOT PHASE IIB STUDY RESULTS PRESENTED AT
EMUC19
SHOWING BOTH PRIMARY AND SECONDARY ENDPOINTS BEING MET
Source text for Eikon: ID:nGNE4GpTxr
Further company coverage: LIDDS.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lidds AB
See all newsBrief: Liquidator To Apply For Lidds To Be Declared Bankrupt
Brief: Lidds To Delist Shares From Nasdaq First North
Brief: Lidds Proposes Voluntary Liquidation And Delisting
Brief: Lidds Decides To Terminate Process Regarding Reverse Acquisition Of Proport Invest
Brief: Lidds Signs Agreement For Reverse Takeover Of Proport Invest